TTK Healthcare Intrinsic Value
TTKHLTCARE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹510.00 | ₹408.00 - ₹612.00 | -41.8% | EPS: ₹42.50, Sector P/E: 12x |
| Book Value Method | asset | ₹760.71 | ₹684.64 - ₹836.78 | -13.2% | Book Value/Share: ₹760.71, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹516.00 | ₹464.40 - ₹567.60 | -41.2% | Revenue/Share: ₹645.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹372.86 | ₹335.57 - ₹410.15 | -57.5% | EBITDA: ₹87.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹350.74 | ₹280.59 - ₹420.89 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹327.16 | ₹294.44 - ₹359.88 | -62.7% | EPS Growth: 9.6%, Fair P/E: 7.7x |
| Growth Adjusted P/E | growth | ₹357.06 | ₹321.35 - ₹392.77 | -59.3% | Revenue Growth: 10.0%, Adj P/E: 8.4x |
| ROE Based Valuation | profitability | ₹438.43 | ₹394.59 - ₹482.27 | -50.0% | ROE: 5.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹852.90 | ₹767.61 - ₹938.19 | -2.7% | EPS: ₹42.50, BVPS: ₹760.71 |
Want to compare with current market value? Check TTKHLTCARE share price latest .
Valuation Comparison Chart
TTKHLTCARE Intrinsic Value Analysis
What is the intrinsic value of TTKHLTCARE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of TTK Healthcare (TTKHLTCARE) is ₹438.43 (median value). With the current market price of ₹876.85, this represents a -50.0% variance from our estimated fair value.
The valuation range spans from ₹327.16 to ₹852.90, indicating ₹327.16 - ₹852.90.
Is TTKHLTCARE undervalued or overvalued?
Based on our multi-method analysis, TTK Healthcare (TTKHLTCARE) appears to be trading above calculated value by approximately 50.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 220.80 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 5.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.70x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for TTK Healthcare
Additional stock information and data for TTKHLTCARE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-25 Cr | ₹-25 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹45 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹96 Cr | ₹58 Cr | Positive Free Cash Flow | 8/10 |